Strain Engineering For Protein Production: From Your Desired Sequence To A GMP-ready Manufacturing Process

Most microbial expression platforms were built for the lab, then scaled up, and the compromises show. Pfenex Expression Technology takes a different approach, engineered from the ground up for commercial biologic production using Pseudomonas fluorescens. The result is a platform that quietly solves some of the industry's most persistent headaches: proteins that misfold in other systems, timelines that stretch development budgets thin, and tech transfers that stall before GMP.
With titers exceeding 30 g/L, an 80% success rate on difficult proteins, and six approved biologics validating the regulatory pathway, explore how Pfenex microbial expression technology is meeting the demands of modern biologic development. Download the brochure to learn more.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.